Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of minimal extended driver nodes in energetic costs reduction.

Chaos (Woodbury, N.Y.)·2024
Same author

Multi-omics peripheral and core regions of cancer.

NPJ systems biology and applications·2022
Same author

Conserved Control Path in Multilayer Networks.

Entropy (Basel, Switzerland)·2022
Same author

C3: connect separate connected components to form a succinct disease module.

BMC bioinformatics·2020
Same author

[Study on determination of eight metal elements in Hainan arecanut leaf by flame atomic absorption spectrophotometry].

Guang pu xue yu guang pu fen xi = Guang pu·2009
Same author

Pseudonocardia endophytica sp. nov., isolated from the pharmaceutical plant Lobelia clavata.

International journal of systematic and evolutionary microbiology·2009
Same journal

Research on a Regional Availability Evaluation Model for Road-Area High-Entropy Energy Based on Synergy Factors.

Entropy (Basel, Switzerland)·2026
Same journal

Atmospheric Turbulence Channel Modeling and Performance Analysis of a CO-ZP-OFDM Coherent Optical Communication System for UAV Air-to-Ground Scenarios.

Entropy (Basel, Switzerland)·2026
Same journal

Information Geometry and Asymptotic Theory for SMML Estimators.

Entropy (Basel, Switzerland)·2026
Same journal

Correlation Entropy and Power-Law Kinetics.

Entropy (Basel, Switzerland)·2026
Same journal

Research on the Contagion of Systemic Financial Risk Under the Impact of Climate Risks-From the Perspective of Complex Networks and Machine Learning.

Entropy (Basel, Switzerland)·2026
Same journal

The Statistical-Mechanical Meaning of the Wave Function of Quantum Mechanics.

Entropy (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jun 14, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

208

Non-Coding RNAs Extended Omnigenic Module of Cancers.

Jie Li1, Bingbo Wang1, Xiujuan Ma1

  • 1School of Computer Science and Technology, Xidian University, Xi'an 710119, China.

Entropy (Basel, Switzerland)
|August 29, 2024
PubMed
Summary
This summary is machine-generated.

Non-coding RNAs (ncRNAs) significantly boost gene connectivity in cancer networks, revealing the Non-coding RNAs extended omnigenic module (NeOModule). This module offers new insights into cancer pathways and treatment targets.

Keywords:
cancer moduleconnectivity patternheterogeneous networknon-coding RNAs

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.3K
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

8.8K

Related Experiment Videos

Last Updated: Jun 14, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

208
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.3K
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

8.8K

Area of Science:

  • Genomics and Bioinformatics
  • Cancer Biology
  • Systems Biology

Background:

  • Cancer development involves complex interactions between coding and non-coding genes.
  • Non-coding RNAs (ncRNAs) play a critical role in cancer, but their network involvement is understudied.
  • Systematic investigation of ncRNAs in cancer gene interaction networks is lacking.

Purpose of the Study:

  • To construct and analyze a gene interaction network incorporating ncRNAs in cancer.
  • To evaluate the topological indicator of connectivity for cancer-affected genes.
  • To identify and characterize a novel ncRNA-mediated module in cancer networks.

Main Methods:

  • Construction of a comprehensive gene interaction network.
  • Application of topological analysis, focusing on gene connectivity.
  • Development of a connectivity-based method to identify the Non-coding RNAs extended omnigenic module (NeOModule).

Main Results:

  • ncRNAs significantly increase the connectivity of genes within the cancer network.
  • ncRNAs facilitate the integration of additional genes into cancer-associated modules.
  • The NeOModule, identified via connectivity, topologically promotes cancer pattern formation and is biologically enriched with cancer pathways and therapeutic targets.

Conclusions:

  • ncRNAs are crucial mediators in cancer gene networks, enhancing connectivity and module expansion.
  • The NeOModule represents a significant cancer-associated network structure.
  • Findings provide valuable insights into cancer relationships, pathways, and potential treatment strategies.